Calpain inhibitor, SJA6017, reduces the rate of formation of selenite cataract in rats

Y. Tamada, C. Fukiage, K. Mizutani, M. Yamaguchi, Y. Nakamura, M. Azuma, Thomas (Tom) Shearer

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

Purposes. 1) To measure the amount of calpain inhibitor SJA6017 taken up by lenses of young rats after administration; and 2) To test efficacy of SJA6017 against selenite cataract in regard to amelioration of proteolysis of lens protein and prevention of lens nuclear opacity. Methods. Selenite nuclear cataracts were produced by subcutaneous injection of an overdose of sodium selenite to 16-day-old rats. SJA6017 was administered daily using intraperitoneal injections at 100 mg/kg body weight/day for 4 days. Lenses were observed and photographed by slit lamp biomicroscopy, and scored into one of three stages. Enucleated lenses were also scored into one of four stages and lens opacities in the nuclear region were quantified by image analysis. Proteolysis of crystallins was detected by SDS-PAGE. The amount of SJA6017 taken up by the lens was detected with a column switching HPLC system. Results. Nuclear cataracts were visible in 31% of the animals receiving only selenite, while the frequency of nuclear cataract in the Se+SJA6017 group was reduced to only 16%. This effect of SJA6017 was confirmed by densitometric analysis as a reduction in the density of the nucleus. Similar proteolytic changes of crystallins occurred at all stages of selenite cataract formation. The amount of SJA6017 in the lens was detected at the level of 0.03 μM. Conclusions. Systemic SJA6017 was taken up by the lens, and SJA6017 amelioratedin vivoselenite cataract formation. These studies are important because they partially validate the biochemical rationale for developing non-surgical, drug treatments for cataract prevention in man.

Original languageEnglish (US)
Pages (from-to)280-285
Number of pages6
JournalCurrent Eye Research
Volume22
Issue number4
DOIs
StatePublished - 2001
Externally publishedYes

Fingerprint

Selenious Acid
Cataract
Lenses
Crystallins
Proteolysis
Sodium Selenite
calpain inhibitors
N-(4-fluorophenylsulfonyl)-L-valyl-L-leucinal
Subcutaneous Injections
Intraperitoneal Injections
Polyacrylamide Gel Electrophoresis
High Pressure Liquid Chromatography
Body Weight

Keywords

  • Calpain
  • Cataract
  • Selenite
  • SJA6017

ASJC Scopus subject areas

  • Ophthalmology
  • Sensory Systems

Cite this

Calpain inhibitor, SJA6017, reduces the rate of formation of selenite cataract in rats. / Tamada, Y.; Fukiage, C.; Mizutani, K.; Yamaguchi, M.; Nakamura, Y.; Azuma, M.; Shearer, Thomas (Tom).

In: Current Eye Research, Vol. 22, No. 4, 2001, p. 280-285.

Research output: Contribution to journalArticle

Tamada, Y, Fukiage, C, Mizutani, K, Yamaguchi, M, Nakamura, Y, Azuma, M & Shearer, TT 2001, 'Calpain inhibitor, SJA6017, reduces the rate of formation of selenite cataract in rats', Current Eye Research, vol. 22, no. 4, pp. 280-285. https://doi.org/10.1076/ceyr.22.4.280.5505
Tamada, Y. ; Fukiage, C. ; Mizutani, K. ; Yamaguchi, M. ; Nakamura, Y. ; Azuma, M. ; Shearer, Thomas (Tom). / Calpain inhibitor, SJA6017, reduces the rate of formation of selenite cataract in rats. In: Current Eye Research. 2001 ; Vol. 22, No. 4. pp. 280-285.
@article{f844d587454d4d7c8e799224b4e0989d,
title = "Calpain inhibitor, SJA6017, reduces the rate of formation of selenite cataract in rats",
abstract = "Purposes. 1) To measure the amount of calpain inhibitor SJA6017 taken up by lenses of young rats after administration; and 2) To test efficacy of SJA6017 against selenite cataract in regard to amelioration of proteolysis of lens protein and prevention of lens nuclear opacity. Methods. Selenite nuclear cataracts were produced by subcutaneous injection of an overdose of sodium selenite to 16-day-old rats. SJA6017 was administered daily using intraperitoneal injections at 100 mg/kg body weight/day for 4 days. Lenses were observed and photographed by slit lamp biomicroscopy, and scored into one of three stages. Enucleated lenses were also scored into one of four stages and lens opacities in the nuclear region were quantified by image analysis. Proteolysis of crystallins was detected by SDS-PAGE. The amount of SJA6017 taken up by the lens was detected with a column switching HPLC system. Results. Nuclear cataracts were visible in 31{\%} of the animals receiving only selenite, while the frequency of nuclear cataract in the Se+SJA6017 group was reduced to only 16{\%}. This effect of SJA6017 was confirmed by densitometric analysis as a reduction in the density of the nucleus. Similar proteolytic changes of crystallins occurred at all stages of selenite cataract formation. The amount of SJA6017 in the lens was detected at the level of 0.03 μM. Conclusions. Systemic SJA6017 was taken up by the lens, and SJA6017 amelioratedin vivoselenite cataract formation. These studies are important because they partially validate the biochemical rationale for developing non-surgical, drug treatments for cataract prevention in man.",
keywords = "Calpain, Cataract, Selenite, SJA6017",
author = "Y. Tamada and C. Fukiage and K. Mizutani and M. Yamaguchi and Y. Nakamura and M. Azuma and Shearer, {Thomas (Tom)}",
year = "2001",
doi = "10.1076/ceyr.22.4.280.5505",
language = "English (US)",
volume = "22",
pages = "280--285",
journal = "Current Eye Research",
issn = "0271-3683",
publisher = "Informa Healthcare",
number = "4",

}

TY - JOUR

T1 - Calpain inhibitor, SJA6017, reduces the rate of formation of selenite cataract in rats

AU - Tamada, Y.

AU - Fukiage, C.

AU - Mizutani, K.

AU - Yamaguchi, M.

AU - Nakamura, Y.

AU - Azuma, M.

AU - Shearer, Thomas (Tom)

PY - 2001

Y1 - 2001

N2 - Purposes. 1) To measure the amount of calpain inhibitor SJA6017 taken up by lenses of young rats after administration; and 2) To test efficacy of SJA6017 against selenite cataract in regard to amelioration of proteolysis of lens protein and prevention of lens nuclear opacity. Methods. Selenite nuclear cataracts were produced by subcutaneous injection of an overdose of sodium selenite to 16-day-old rats. SJA6017 was administered daily using intraperitoneal injections at 100 mg/kg body weight/day for 4 days. Lenses were observed and photographed by slit lamp biomicroscopy, and scored into one of three stages. Enucleated lenses were also scored into one of four stages and lens opacities in the nuclear region were quantified by image analysis. Proteolysis of crystallins was detected by SDS-PAGE. The amount of SJA6017 taken up by the lens was detected with a column switching HPLC system. Results. Nuclear cataracts were visible in 31% of the animals receiving only selenite, while the frequency of nuclear cataract in the Se+SJA6017 group was reduced to only 16%. This effect of SJA6017 was confirmed by densitometric analysis as a reduction in the density of the nucleus. Similar proteolytic changes of crystallins occurred at all stages of selenite cataract formation. The amount of SJA6017 in the lens was detected at the level of 0.03 μM. Conclusions. Systemic SJA6017 was taken up by the lens, and SJA6017 amelioratedin vivoselenite cataract formation. These studies are important because they partially validate the biochemical rationale for developing non-surgical, drug treatments for cataract prevention in man.

AB - Purposes. 1) To measure the amount of calpain inhibitor SJA6017 taken up by lenses of young rats after administration; and 2) To test efficacy of SJA6017 against selenite cataract in regard to amelioration of proteolysis of lens protein and prevention of lens nuclear opacity. Methods. Selenite nuclear cataracts were produced by subcutaneous injection of an overdose of sodium selenite to 16-day-old rats. SJA6017 was administered daily using intraperitoneal injections at 100 mg/kg body weight/day for 4 days. Lenses were observed and photographed by slit lamp biomicroscopy, and scored into one of three stages. Enucleated lenses were also scored into one of four stages and lens opacities in the nuclear region were quantified by image analysis. Proteolysis of crystallins was detected by SDS-PAGE. The amount of SJA6017 taken up by the lens was detected with a column switching HPLC system. Results. Nuclear cataracts were visible in 31% of the animals receiving only selenite, while the frequency of nuclear cataract in the Se+SJA6017 group was reduced to only 16%. This effect of SJA6017 was confirmed by densitometric analysis as a reduction in the density of the nucleus. Similar proteolytic changes of crystallins occurred at all stages of selenite cataract formation. The amount of SJA6017 in the lens was detected at the level of 0.03 μM. Conclusions. Systemic SJA6017 was taken up by the lens, and SJA6017 amelioratedin vivoselenite cataract formation. These studies are important because they partially validate the biochemical rationale for developing non-surgical, drug treatments for cataract prevention in man.

KW - Calpain

KW - Cataract

KW - Selenite

KW - SJA6017

UR - http://www.scopus.com/inward/record.url?scp=0034832186&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034832186&partnerID=8YFLogxK

U2 - 10.1076/ceyr.22.4.280.5505

DO - 10.1076/ceyr.22.4.280.5505

M3 - Article

VL - 22

SP - 280

EP - 285

JO - Current Eye Research

JF - Current Eye Research

SN - 0271-3683

IS - 4

ER -